Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Genetic variability in inflammation pathways and prostate cancer risk.

Sun J, Turner A, Xu J, Grönberg H, Isaacs W.

Urol Oncol. 2007 May-Jun;25(3):250-9. Review.

PMID:
17483024
2.

Interactions of sequence variants in interleukin-1 receptor-associated kinase4 and the toll-like receptor 6-1-10 gene cluster increase prostate cancer risk.

Sun J, Wiklund F, Hsu FC, Bälter K, Zheng SL, Johansson JE, Chang B, Liu W, Li T, Turner AR, Li L, Li G, Adami HO, Isaacs WB, Xu J, Grönberg H.

Cancer Epidemiol Biomarkers Prev. 2006 Mar;15(3):480-5.

3.

The role of inflammation in the pathogenesis of prostate cancer.

Nelson WG, De Marzo AM, DeWeese TL, Isaacs WB.

J Urol. 2004 Nov;172(5 Pt 2):S6-11; discussion S11-2. Review.

PMID:
15535435
4.

Prostate cancer susceptibility genes: lessons learned and challenges posed.

Simard J, Dumont M, Labuda D, Sinnett D, Meloche C, El-Alfy M, Berger L, Lees E, Labrie F, Tavtigian SV.

Endocr Relat Cancer. 2003 Jun;10(2):225-59. Review.

5.

A comprehensive association study for genes in inflammation pathway provides support for their roles in prostate cancer risk in the CAPS study.

Zheng SL, Liu W, Wiklund F, Dimitrov L, Bälter K, Sun J, Adami HO, Johansson JE, Sun J, Chang B, Loza M, Turner AR, Bleecker ER, Meyers DA, Carpten JD, Duggan D, Isaacs WB, Xu J, Grönberg H.

Prostate. 2006 Oct 1;66(14):1556-64.

PMID:
16921508
6.
7.

Common sequence variants of the macrophage scavenger receptor 1 gene are associated with prostate cancer risk.

Xu J, Zheng SL, Komiya A, Mychaleckyj JC, Isaacs SD, Chang B, Turner AR, Ewing CM, Wiley KE, Hawkins GA, Bleecker ER, Walsh PC, Meyers DA, Isaacs WB.

Am J Hum Genet. 2003 Jan;72(1):208-12. Epub 2002 Dec 6.

8.

The role of inflammation and infection in the pathogenesis of prostate carcinoma.

Wagenlehner FM, Elkahwaji JE, Algaba F, Bjerklund-Johansen T, Naber KG, Hartung R, Weidner W.

BJU Int. 2007 Oct;100(4):733-7. Epub 2007 Jul 23. Review.

9.

No association of germline alteration of MSR1 with prostate cancer risk.

Wang L, McDonnell SK, Cunningham JM, Hebbring S, Jacobsen SJ, Cerhan JR, Slager SL, Blute ML, Schaid DJ, Thibodeau SN.

Nat Genet. 2003 Oct;35(2):128-9. Epub 2003 Sep 7.

PMID:
12958598
10.

The complex genetic epidemiology of prostate cancer.

Schaid DJ.

Hum Mol Genet. 2004 Apr 1;13 Spec No 1:R103-21. Epub 2004 Jan 28. Review.

11.

Association between Toll-like receptor gene cluster (TLR6, TLR1, and TLR10) and prostate cancer.

Chen YC, Giovannucci E, Kraft P, Lazarus R, Hunter DJ.

Cancer Epidemiol Biomarkers Prev. 2007 Oct;16(10):1982-9.

12.

Germline mutations and sequence variants of the macrophage scavenger receptor 1 gene are associated with prostate cancer risk.

Xu J, Zheng SL, Komiya A, Mychaleckyj JC, Isaacs SD, Hu JJ, Sterling D, Lange EM, Hawkins GA, Turner A, Ewing CM, Faith DA, Johnson JR, Suzuki H, Bujnovszky P, Wiley KE, DeMarzo AM, Bova GS, Chang B, Hall MC, McCullough DL, Partin AW, Kassabian VS, Carpten JD, Bailey-Wilson JE, Trent JM, Ohar J, Bleecker ER, Walsh PC, Isaacs WB, Meyers DA.

Nat Genet. 2002 Oct;32(2):321-5. Epub 2002 Sep 16.

PMID:
12244320
13.

Toll-like receptor 4 genetic variation and advanced prostate cancer risk.

Cheng I, Plummer SJ, Casey G, Witte JS.

Cancer Epidemiol Biomarkers Prev. 2007 Feb;16(2):352-5.

14.

Inflammation in the etiology of prostate cancer: an epidemiologic perspective.

Sutcliffe S, Platz EA.

Urol Oncol. 2007 May-Jun;25(3):242-9. Review.

PMID:
17483023
15.

Prostatitis as a risk factor for prostate cancer.

Roberts RO, Bergstralh EJ, Bass SE, Lieber MM, Jacobsen SJ.

Epidemiology. 2004 Jan;15(1):93-9.

PMID:
14712152
16.

Genetic variation in the SST gene and its receptors in relation to circulating levels of insulin-like growth factor-I, IGFBP3, and prostate cancer risk.

Johansson M, McKay JD, Wiklund F, Rinaldi S, Hallmans G, Bälter K, Adami HO, Grönberg H, Stattin P, Kaaks R.

Cancer Epidemiol Biomarkers Prev. 2009 May;18(5):1644-50. doi: 10.1158/1055-9965.EPI-08-0893.

17.

Prostate cancer epidemiology.

Hsing AW, Chokkalingam AP.

Front Biosci. 2006 May 1;11:1388-413. Review.

PMID:
16368524
18.

[Chronic prostatitis--risk factor in development of prostatic cancer (review)].

Mazo EB, Kozdoba AS.

Ter Arkh. 2007;79(10):66-73. Review. Russian. No abstract available.

PMID:
18154149
19.

Inflammation and prostate cancer.

Sugar LM.

Can J Urol. 2006 Feb;13 Suppl 1:46-7.

PMID:
16526982
20.

Prostate carcinogenesis and inflammation: emerging insights.

Palapattu GS, Sutcliffe S, Bastian PJ, Platz EA, De Marzo AM, Isaacs WB, Nelson WG.

Carcinogenesis. 2005 Jul;26(7):1170-81. Epub 2004 Oct 21. Review.

Items per page

Supplemental Content

Write to the Help Desk